High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus

References

• Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients – a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 2010;26;8:62.
   Web of Science ®Google Scholar
• Van Dieren S, Beulens JW, Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010;17:3–8.
   PubMed Web of Science ®Google Scholar
• Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 1997;12:1187–91.
   PubMed Web of Science ®Google Scholar
• Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000;49:1399–408.
   PubMed Web of Science ®Google Scholar
• Pinelli NR, Jantz AS, Martin ET, Jaber LA. Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 2011;96:1680–3.
   Web of Science ®Google Scholar
• Parrinello CM, Selvin E. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep 2014;14:548.
   PubMed Web of Science ®Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;29:1058–70.
   Web of Science ®Google Scholar
• Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405–12.
   PubMed Web of Science ®Google Scholar
• Kaefer M, De Carvalho JA, Piva SJ, da Silva DB, Becker AM, Sangoi MB, Almeida TC, Hermes CL, Coelho AC, Tonello R, Moreira AP, Garcia SC, Moretto MB. Plasma malondialdehyde levels and risk factors for the development of chronic complications in type 2 diabetic patients on insulin therapy. Clin Lab 2012;58:973–8.
   PubMed Web of Science ®Google Scholar
• Pandey KB, Mishra N, Rizvi SI. Protein oxidation biomarkers in plasma of type 2 diabetic patients. Clin Biochem 2010;43:508–11.
   PubMed Web of Science ®Google Scholar
• Knapik-Kordecka M, Piwowar A, Warwas M. Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2. Wiad Lek 2007;60:329–34.
   PubMedGoogle Scholar
• Kaefer M, Piva SJ, De Carvalho JA, Da Silva DB, Becker AM, Coelho AC, Duarte MM, Moresco RN. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010;43:450–4.
   PubMed Web of Science ®Google Scholar
• Kirimi E, Peker E, Tuncer O, Yapicioglu H, Narli N, Satar M. Increased serum malondialdehyde level in neonates with hypoxic-ischaemic encephalopathy: prediction of disease severity. J Int Med Res 2010;38:220–6.
   PubMed Web of Science ®Google Scholar
• Liang X, Chen Y, Zhuang J, Zhang M, Xiong W, Guo H, Jiang F, Hu P, Guo D, Shi W. Advanced oxidation protein products as prognostic biomarkers for recovery from acute kidney injury after coronary artery bypass grafting. Biomarkers 2012;17:507–12.
   PubMed Web of Science ®Google Scholar
• Dursun A, Okumus N, Zenciroglu A. Ischemia-modified albumin (IMA): could it be useful to predict perinatal asphyxia? J Matern Fetal Neonatal Med 2012;25:2401–5.
   PubMed Web of Science ®Google Scholar
• Beisswenger PJ. Glycation and biomarkers of vascular complications of diabetes. Amino Acids 2012;42:1171–83.
   PubMed Web of Science ®Google Scholar
• Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. American Diabetic Association Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–97.
   Google Scholar
• Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia – a preliminary report. J Emerg Med 2000;19:311–15.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–13.
   PubMed Web of Science ®Google Scholar
• Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37–43.
   PubMed Web of Science ®Google Scholar
• Liang M, Wang J, Xie C, Yang Y, Tian JW, Xue YM, Hou FF. Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria 2. J Diabetes 2014;6:417–26.
   PubMed Web of Science ®Google Scholar
• Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, Kocak M. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 2009;36:425–32.
   PubMed Web of Science ®Google Scholar
• Vicentini J, Valentini J, Grotto D, Paniz C, Roehrs M, Brucker N, Charão MF, Moro AM, Tonello R, Moreira AP, Buffon A, Beck M, Garcia SC. Association among microalbuminuria and oxidative stress biomarkers in patients with type 2 diabetes. J Investig Med 2011;59:649–54.
   PubMed Web of Science ®Google Scholar
• Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 2000;26:387–92.
   PubMed Web of Science ®Google Scholar
• Oranje WA, Rondas-Colbers GJ, Swennen GN, Wolffenbuttel BH. Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease? Neth J Med 1998;53:61–8.
   PubMed Web of Science ®Google Scholar
• Velázquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med 1991;8:752–8.
   PubMed Web of Science ®Google Scholar
• Dahiya K, Aggarwal K, Seth S, Singh V, Sharma TK. Type 2 diabetes mellitus without vascular complications and ischemia modified albumin. Clin Lab 2010;56:187–90.
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus – preliminary report. Dis Markers 2008;24:311–17.
   PubMed Web of Science ®Google Scholar
• Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, Fulcher G, de Galan BE, Harrap S, Hamet P, Heller S, MacMahon S, Marre M, Poulter N,Travert F, Patel A, Neal B, Woodward M, Advance Collaborative Group. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 2012; 55:636–43.
   PubMed Web of Science ®Google Scholar
• Andersson C, van Gaal L, Caterson ID, Weeke P, James WP, Coutinho W, Finer N, Sharma AM, Maggioni AP, Torp-Pedersen C. Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia 2012;55:2348–55.
   PubMed Web of Science ®Google Scholar
• Krzystek-Korpacka M, Salmonowicz B, Boehm D, Berdowska I, Zielinski B, Patryn E, Noczynska A, Gamian A. Diagnostic potential of oxidative stress markers in children and adolescents with type 1 diabetes. Clin Biochem 2008;41:48–55.
   PubMed Web of Science ®Google Scholar
• Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina 2011;31:602–8.
   PubMed Web of Science ®Google Scholar
• Ma SG, Jin Y, Hu W, Bai F, Xu W, Yu WN. Evaluation of ischemia-modified albumin and C-reactive protein in type 2 diabetics with and without ketosis. Biomark Insights 2012;7:19–26.
   PubMedGoogle Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients. Clin Invest Med 2010;33:E109.
   PubMed Web of Science ®Google Scholar
• Hjortshøj S, Kristensen SR, Ravkilde J. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 2010;28:170–6.
   PubMed Web of Science ®Google Scholar